The future of healthcare is defined by this blend of technology and human expertise, offering new hope for a more efficient ...
Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.
These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...
An unusual swelling in the legs and feet could indicate the onset of kidney damage. When the kidneys struggle to eliminate ...
The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...
This model exhibits ... New Method Predicts Worsening of Chronic Kidney Disease Sep. 12, 2024 — Researchers have developed a new method that could be a significant step in the treatment of ...
Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results ...
Lithium is associated with an increased risk for thyroid dysfunction and chronic kidney disease (CKD) in patients with ...
Since kidney disease often progresses without noticeable symptoms in the early stages, its important to stay vigilant and ...
Health and Me on MSN3d
GLP-1 Drugs Could Be Used To Treat Chronic Kidney DiseaseA latest research led by Dr Shuyao Zhang, an assistant professor of internal medicine at UT Southwestern in Dallas reveal the ...
Duncan, who has chronic kidney disease, has worked with dance companies in Chicago and around the world over his decades-long ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results